Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
60 hedge funds and large institutions have $189M invested in Akoya BioSciences in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
27.12% more ownership
Funds ownership: 0% → 27.12% (+27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$46.3M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$22.1M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$14.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.3M |
| 5 |
BlackRock
New York
|
+$9.12M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Legal & General Group
London,
United Kingdom
| $16K | +$16.6K | +802 | New |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| $12K | +$12.4K | +599 | New |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | +$10.8K | +523 | New |
|
54
Citigroup
New York
| $7K | +$7.5K | +363 | New |
|
55
Osaic Holdings
Scottsdale,
Arizona
| $5K | +$5.08K | +246 | New |
|
|
PCH
56
Polar Capital Holdings
London,
United Kingdom
| $4.83K | +$5.16M | +250,000 | New |
|
57
UBS Group
Zurich,
Switzerland
| $4K | +$4.61K | +223 | New |
|
|
ASN
58
Advisory Services Network
Atlanta,
Georgia
| $1K | +$1.14K | +55 | New |
|
59
Walleye Capital
New York
| $593 | +$634K | +30,687 | New |
|
|
AIG
60
American International Group
New York
| $83 | +$88.4K | +4,279 | New |
|
AKYA Hedge Fund Activity: Q2 2021 in Review
60 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2021, worth a combined $189M.
Buyers outnumbered sellers: 60 funds opened new AKYA positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $46.3M.
- 60 institutional investors held Akoya BioSciences (AKYA) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $189M of Akoya BioSciences stock for Q2 2021.
- 60 funds opened new Akoya BioSciences positions in Q2 2021 and 0 closed out, a net change of +60 holders.
- The largest Akoya BioSciences buyer in Q2 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $46.3M added.
Based on aggregated 13F filings for Q2 2021.